Increasing the prescription rate of β-blockers is beneficial for patients with chronic obstructive pulmonary and cardiovascular disease

Eur Heart J. 2021 Sep 7;42(34):3409. doi: 10.1093/eurheartj/ehab239.

¹ Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
² Beijing Zhiyun Data Technology Co. Ltd, No. 1397, New Materials Chuangye Building, 7 Fenghui Zhong Lu, Haidian District, Beijing 100094, China.
³ Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China.

No abstract available

Publication types